Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 40
Filtrar
3.
Bull World Health Organ ; 80(5): 342-9, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12077608

RESUMEN

OBJECTIVE: To assess the sensitivity, specificity and predictive value positive of the WHO threshold strategy for detecting meningococcal disease epidemics in sub-Saharan Africa and to estimate the impact of the strategy on an epidemic at district level. METHODS: Data on meningitis cases at the district level were collected weekly from health ministries, WHO country and regional offices, and nongovernmental organizations in countries where there were epidemics of meningococcal disease in 1997. An epidemic was defined as a cumulative district attack rate of at least 100 cases per 100,000 population from January to May, the period of epidemic risk. The sensitivity, specificity and predictive value positive of the WHO threshold rate were calculated, and curves of sensitivity against (1 - specificity) were compared with alternatively defined threshold rates and epidemic sizes. The impact of the WHO strategy on a district epidemic was estimated by comparing the numbers of epidemic cases with cases estimated to have been prevented by vaccination. FINDINGS: An analysis was made of 48 198 cases reported in 174 districts in Benin, Burkina Faso, the Gambia, Ghana, Mali, Niger, and Togo. These cases were 80.3% of those reported from Africa to WHO during the 1997 epidemic period. District populations ranged from 10,298 to 573,908. The threshold rate was crossed during two consecutive weeks in 69 districts (39.7%) and there were epidemics in 66 districts (37.9%). Overall, the sensitivity of the threshold rate for predicting epidemics was 97%, the specificity was 95%, and the predictive value positive was 93%. Taken together, these values were equivalent or better than the sensitivity, specificity and predictive value positive of alternatively defined threshold rates and epidemics, and remained high regardless of district size. The estimated number of potential epidemic cases decreased by nearly 60% in the age group targeted for vaccination in one district where the guidelines were followed in a timely manner. CONCLUSION: The use of the WHO strategy was sensitive and specific for the early detection of meningococcal disease epidemics in countries of sub-Saharan Africa during 1997 and had a substantial impact on a district epidemic. Nevertheless, the burden of meningococcal disease in these countries remains formidable and additional control measures are needed.


Asunto(s)
Brotes de Enfermedades/prevención & control , Infecciones Meningocócicas/epidemiología , África del Sur del Sahara/epidemiología , Notificación de Enfermedades , Humanos , Infecciones Meningocócicas/diagnóstico , Infecciones Meningocócicas/prevención & control , Vigilancia de la Población/métodos , Sensibilidad y Especificidad , Organización Mundial de la Salud
5.
Pediatrics ; 108(4): E60, 2001 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11581468

RESUMEN

OBJECTIVE: To identify reservoirs of Haemophilus influenzae type b (Hib) pharyngeal carriage and assess barriers to vaccination among 2 Amish communities in Pennsylvania. METHODS: We investigated recent cases, performed community surveys for Hib vaccination coverage and pharyngeal carriage, and administered a questionnaire assessing vaccination knowledge and attitudes to 298 members of 2 Amish communities (A and B) in Pennsylvania and, as a comparison group, 136 non-Amish family members who participated in state immunization clinics. From December 1999 to February 2000, 8 cases of invasive Hib disease occurred among children who were 5 years of age or younger in Pennsylvania. Six of the case-patients were from Amish communities. None of the children had been vaccinated. RESULTS: Among children who were 5 years of age or younger, Hib vaccine coverage was low in the 2 Amish communities: A (9 [28%] of 32) and B (3 [7%] of 41) compared with the non-Amish group (19 [95%] of 20). Hib carriage prevalence was higher in both Amish communities than in the non-Amish group (A: 3%; B: 8%; non-Amish: 0%). More households in community B had 1 or more Hib carriers than in community A (8 [28%] of 29 vs 3 [9%] of 32). Among Amish parents who did not vaccinate their children, only 25% (13 of 51) identified either religious or philosophical objections as a factor; 51% (26 of 51) reported that vaccinating was not a priority compared with other activities of daily life. Seventy-three percent (36 of 49) would vaccinate their children if vaccination were offered locally. CONCLUSIONS: Undervaccinated communities in the United States still exist and allow circulation of Hib strains, resulting in disease among susceptible children. Identification of undervaccinated populations, such as the Amish, and targeted education and vaccination campaigns are essential to achieving elimination of Hib disease.


Asunto(s)
Infecciones por Haemophilus/epidemiología , Vacunas contra Haemophilus/uso terapéutico , Haemophilus influenzae tipo b , Adolescente , Adulto , Factores de Edad , Portador Sano/epidemiología , Niño , Preescolar , Etnicidad/psicología , Infecciones por Haemophilus/prevención & control , Haemophilus influenzae tipo b/inmunología , Haemophilus influenzae tipo b/aislamiento & purificación , Conocimientos, Actitudes y Práctica en Salud , Encuestas Epidemiológicas , Humanos , Inmunización/psicología , Programas de Inmunización/estadística & datos numéricos , Esquemas de Inmunización , Lactante , Padres/psicología , Pennsylvania/epidemiología , Faringe/microbiología , Religión y Medicina , Estados Unidos/epidemiología
6.
Vaccine ; 19(31): 4566-75, 2001 Aug 14.
Artículo en Inglés | MEDLINE | ID: mdl-11483285

RESUMEN

BACKGROUND: Neisseria meningitidis is a leading cause of bacterial meningitis in US; new capsular type-specific conjugate vaccines offer an opportunity for improved control of meningococcal disease. We evaluated the relative burdens of invasive meningococcal disease in US and examined the projected impact of various meningococcal conjugate vaccination strategies on rates of meningococcal disease. METHODS: Meningococcal disease incidence rates were determined from active, population-based surveillance in selected US areas. Models were created to determine impact of vaccination of infants, toddlers, adolescents or college students with meningococcal conjugate vaccines, with assumptions for vaccine coverage, efficacy and duration of protection. Although we examined possible conjugate vaccine formulations including serogroups A, C, Y and W-135, the final vaccine impact analysis excluded serogroups A and W-135. Outcome measures were cumulative meningococcal disease incidence, and incidence 10 years after initiating vaccination among 0-22-year-olds. RESULTS: In models of serogroup C+Y meningococcal conjugate vaccination of infants, toddlers and adolescents, the cumulative incidence of meningococcal disease was reduced by 54, 48 and 25%, respectively; the toddler strategy had the greatest impact per dose. After 10 years of routine meningococcal conjugate vaccination, meningococcal disease could be reduced by 50% and deaths by 64%. CONCLUSIONS: Use of meningococcal conjugate vaccine could markedly reduce meningococcal disease incidence. Our data, along with vaccine formulation and vaccination program considerations, will be important in determining the optimal choice of vaccination strategy.


Asunto(s)
Programas de Inmunización/métodos , Infecciones Meningocócicas/prevención & control , Vacunas Meningococicas/uso terapéutico , Neisseria meningitidis/inmunología , Vigilancia de la Población/métodos , Adolescente , Adulto , Niño , Preescolar , Humanos , Incidencia , Lactante , Recién Nacido , Infecciones Meningocócicas/epidemiología , Estados Unidos/epidemiología , Vacunas Conjugadas/uso terapéutico
7.
JAMA ; 286(6): 688-93, 2001 Aug 08.
Artículo en Inglés | MEDLINE | ID: mdl-11495618

RESUMEN

CONTEXT: Elevated rates of meningococcal disease were noted among 18- to 22-year-olds in the mid-1990s. However, national data on rates of meningococcal disease in US college students were not collected until 1998. OBJECTIVES: To determine rates of meningococcal disease in US college students and to identify risk factors for meningococcal disease in this population. DESIGN, SETTING, AND PATIENTS: Prospective surveillance study with nested case-control study of US college students with meningococcal infection from September 1, 1998, to August 31, 1999. Fifty state health departments and 231 college health centers participated. MAIN OUTCOME MEASURES: Incidence of and risk factors for meningococcal disease in US college students. RESULTS: Ninety-six cases of meningococcal disease were identified. The incidence rate for undergraduates was 0.7 per 100 000 persons vs 1.4 per 100 000 for the general population of 18- to 23-year-old nonstudents (P<.001). Freshmen living in dormitories had the highest incidence rate at 5.1 per 100 000. Of the 79 case-patients for whom information was available, 54 (68%) had illness due to vaccine-preventable meningococcal serogroups. On multivariable analysis of case-control study data, freshmen who lived in dormitories had an elevated risk of meningococcal disease (matched odds ratio, 3.6; 95% confidence interval, 1.6-8.5; P =.003) compared with other college students. CONCLUSIONS: Freshmen who live in dormitories have an independent, elevated risk of meningococcal disease compared with other college students. Use of the currently available quadrivalent polysaccharide vaccine among college students could substantially decrease their risk of meningococcal disease.


Asunto(s)
Infecciones Meningocócicas/epidemiología , Estudiantes , Universidades , Adolescente , Adulto , Estudios de Casos y Controles , Femenino , Vivienda , Humanos , Incidencia , Modelos Logísticos , Masculino , Infecciones Meningocócicas/prevención & control , Vacunas Meningococicas , Análisis Multivariante , Estudios Prospectivos , Factores de Riesgo , Estudiantes/estadística & datos numéricos , Estados Unidos/epidemiología , Universidades/estadística & datos numéricos , Vacunación
8.
JAMA ; 286(6): 694-9, 2001 Aug 08.
Artículo en Inglés | MEDLINE | ID: mdl-11495619

RESUMEN

CONTEXT: Incidence of invasive meningococcal disease has increased recently in persons aged 15 through 24 years. OBJECTIVE: To characterize meningococcal infection in adolescents and young adults in Maryland during the 1990s. DESIGN AND SETTING: Population-based surveillance study for meningococcal disease from January 1, 1990, through December 31, 1999, in Maryland. PATIENTS: Maryland residents diagnosed as having invasive meningococcal disease. MAIN OUTCOME MEASURE: Invasive meningococcal infection. RESULTS: Of 295 total cases, 71 (24.1%) occurred among persons aged 15 through 24 years. Sixteen (22.5%) of these cases were fatal. The annual incidence rate increased from 0.9 to 2.1 cases per 100 000 among 15 through 24 year olds (P =.01). The proportion of all disease increased from 16.0% to 28.9% (P =.03). The incidence and proportion of cases subsequently decreased to 1.0 and 16.4% in 1998 through 1999, respectively. Infection in 15 through 24 year olds was more likely to be fatal than infection in those younger than age 15 years (22.5% vs 4.6%; P =.001). Infection in 15 through 24 year olds, compared with those aged 25 years or older, was more likely to be associated with male sex (66.2% vs 34.8%; P<.001) and serogroup C infection (46.9% vs 20.2%; P<.001), respectively. Infections were potentially preventable with the licensed meningococcal vaccine in 82.8% of 15 through 24 year olds, 68.1% of those younger than 15 years, and 76.8% of adults aged 25 years or older. CONCLUSIONS: Incidence of meningococcal infection in 15 through 24 year olds in Maryland increased and then declined during the 1990s. Infection in this age group was associated with an unusually high case-fatality ratio, and the vast majority of cases were potentially vaccine preventable.


Asunto(s)
Infecciones Meningocócicas/epidemiología , Adolescente , Adulto , Femenino , Humanos , Incidencia , Masculino , Maryland/epidemiología , Infecciones Meningocócicas/mortalidad , Infecciones Meningocócicas/prevención & control , Vacunas Meningococicas , Neisseria meningitidis/clasificación , Vigilancia de la Población , Serotipificación , Vacunación
11.
South Med J ; 94(5): 482-5, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11372796

RESUMEN

BACKGROUND: We examined the role of social networks and marijuana smoking in a community outbreak of infections due to Neisseria meningitidis. METHODS: We interviewed all patients and their contacts. Isolates were tested by pulsed field electrophoresis and multilocus enzyme electrophoresis. RESULTS: Nine cases of meningococcal disease occurred in the outbreak; isolates from seven cases with positive cultures were identical. Multiple overlapping social networks were found for case-patients and their contacts. All case-patients were linked by the marijuana-related activities of their contacts. CONCLUSION: Investigation of social networks and marijuana exposure might help identify close contacts of patients with meningococcal disease and help prevent secondary infections.


Asunto(s)
Trazado de Contacto , Brotes de Enfermedades/prevención & control , Fumar Marihuana/efectos adversos , Infecciones Meningocócicas/epidemiología , Neisseria meningitidis , Adolescente , Adulto , Bacteriemia/epidemiología , Bacteriemia/etiología , Bacteriemia/microbiología , Niño , Preescolar , Femenino , Florida/epidemiología , Humanos , Masculino , Meningitis Meningocócica/epidemiología , Meningitis Meningocócica/etiología , Infecciones Meningocócicas/etiología , Infecciones Meningocócicas/microbiología , Neisseria meningitidis/aislamiento & purificación
12.
Infect Dis Clin North Am ; 15(1): 155-69, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11301813

RESUMEN

Global control and prevention of meningococcal disease depends on the further development of vaccines that overcome the limitations of the current polysaccharide vaccines. Protein-polysaccharide conjugate vaccines likely will address the marginal protective antibody responses and short duration of immunity in young children derived from the A, C, Y, and W-135 capsular polysaccharides, but they will be expensive to produce and purchase, and may not offer a practical solution to the countries with greatest need. In addition, OMP vaccines have been tested extensively in humans and hold some promise in the development of a serogroup B vaccine, but are limited by the antigenic variability of these subcapsular antigens and the resulting strain-specific protection. Elimination of meningococcal disease likely will require a novel approach to vaccine development, ideally incorporating a safe and effective antigen or antigens common to all meningoccocal serogroups. As a solely human pathogen, however, N. meningitidis has developed many tools with which to evade the human immune system, and likely will pose a formidable challenge for years to come.


Asunto(s)
Infecciones Meningocócicas/prevención & control , Vacunas Meningococicas , Vacunación , Adolescente , Antígenos Bacterianos/inmunología , Proteínas de la Membrana Bacteriana Externa/inmunología , Ensayos Clínicos como Asunto , Humanos , Infecciones Meningocócicas/microbiología , Vacunas Meningococicas/administración & dosificación , Vacunas Meningococicas/inmunología , Neisseria meningitidis/inmunología , Factores de Riesgo , Estudiantes
13.
Clin Infect Dis ; 32(5): 708-15, 2001 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-11229838

RESUMEN

Surveillance for coccidioidomycosis (CM) and a case-control study for risk factors among adults were conducted in Kern County, California. From January 1995 through December 1996, 905 cases of CM were identified, for an annual incidence of 86 cases per 100,000 population. A total of 380 adults were enrolled in the case-control study: 77 had severe pulmonary disease, 33 had disseminated disease, and 270 control patients had mild disease. Independent risk factors for severe pulmonary disease included diabetes, recent history of cigarette smoking, income of < $15,000 per year, and older age. Oral antifungal therapy before hospitalization was associated with a reduced risk of CM pneumonia. Risk factors for disseminated disease were black race, income of < $15,000 per year, and pregnancy. Early treatment of CM with oral antifungal agents may prevent severe pulmonary disease in groups considered to be at high risk, such as elderly individuals, persons with diabetes, and smokers. Persons at risk for severe CM may benefit from vaccination once an effective CM vaccine is available.


Asunto(s)
Coccidioides/aislamiento & purificación , Coccidioidomicosis/epidemiología , Enfermedades Pulmonares Fúngicas/epidemiología , Vigilancia de la Población , Adulto , California/epidemiología , Estudios de Casos y Controles , Coccidioides/clasificación , Coccidioides/genética , Coccidioidomicosis/microbiología , Coccidioidomicosis/fisiopatología , Femenino , Humanos , Incidencia , Enfermedades Pulmonares Fúngicas/microbiología , Enfermedades Pulmonares Fúngicas/fisiopatología , Masculino , Análisis Multivariante , Factores de Riesgo
15.
J Clin Microbiol ; 39(1): 75-85, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11136752

RESUMEN

Since 1990, the frequency of Neisseria meningitidis serogroup C (NMSC) outbreaks in the United States has increased. Based on multilocus enzyme electrophoresis (MEE), the current molecular subtyping standard, most of the NMSC outbreaks have been caused by isolates of several closely related electrophoretic types (ETs) within the ET-37 complex. We chose 66 isolates from four well-described NMSC outbreaks that occurred in the United States from 1993 to 1995 to evaluate the potential of pulsed-field gel electrophoresis (PFGE) to identify outbreak-related isolates specific for each of the four outbreaks and to differentiate between them and 50 sporadic isolates collected during the outbreak investigations or through active laboratory-based surveillance from 1989 to 1996. We tested all isolates collected during the outbreak investigations by four other molecular subtyping methods: MEE, ribotyping (ClaI), random amplified polymorphic DNA assay (two primers), and serotyping and serosubtyping. Among the 116 isolates, we observed 11 clusters of 39 NheI PFGE patterns. Excellent correlation between the PFGE and the epidemiological data was observed, with an overall sensitivity of 85% and specificity of 71% at the 95% pattern relatedness breakpoint using either 1.5 or 1.0% tolerance. For all four analyzed outbreaks, PFGE would have given public health officials additional support in declaring an outbreak and making appropriate public health decisions.


Asunto(s)
Brotes de Enfermedades , Electroforesis en Gel de Campo Pulsado , Meningitis Meningocócica/epidemiología , Meningitis Meningocócica/microbiología , Neisseria meningitidis/clasificación , Neisseria meningitidis/aislamiento & purificación , Arizona/epidemiología , California/epidemiología , Humanos , Neisseria meningitidis/genética , New Mexico/epidemiología , Vigilancia de la Población , Técnica del ADN Polimorfo Amplificado Aleatorio , Ribotipificación , Sensibilidad y Especificidad , Serotipificación , Texas/epidemiología
16.
Methods Mol Med ; 67: 333-9, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-21337154

RESUMEN

The word "surveillance" probably first referred to close supervision of individuals exposed to an infectious disease and their close contacts (1). Currently, though, surveillance refers more frequently to the ongoing accumulation of data so that it can be used for decision-making. A surveillance system includes collection, analysis, and dissemination of data. Surveillance can be used to evaluate trends in disease, to identify outbreaks, to test hypotheses, to evaluate existing programs, and to plan for new programs. Surveillance is the single most important tool for identifying infectious diseases that are emerging, are causing serious public health problems, or are diminishing in importance (2).

17.
Methods Mol Med ; 67: 341-56, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-21337155

RESUMEN

Invasive disease caused by Neisseria meningitidis is one of the leading infectious causes of death in childhood in North America (1), but its prevention has not received the same priority on the health agenda as in Europe, Australia, and New Zealand. There are several likely explanations, but the principal one is that disease incidence appears to be lower in both Canada (2) and the United States (3) than in some of these other countries (4,5). Here, we describe recent epidemiological data concerning meningococcal infection in Canada and the United States and comment on the possible future introduction of vaccination to prevent meningococcal disease across the continent.

19.
Sante ; 11(4): 251-5, 2001.
Artículo en Francés | MEDLINE | ID: mdl-11861202

RESUMEN

In sub-Saharan Africa, the control of meningococcal meningitis epidemics relies on early epidemic detection and mass vaccination. However, experience shows that interventions are often initiated too late to have a significant impact on the epidemic. A new recommendation drafted by participants of a consensus meeting proposes an alert threshold and an epidemic threshold based on the weekly number or incidence of meningitis cases, according to the population size and the epidemic risk, resulting in indicators with high sensitivity and specificity for the detection of an emerging epidemic. Meningitis outbreak investigations must include an assessment of the quality of epidemiologic surveillance. The new recommendation is published in English and French in the Weekly Epidemiologic Record [12]. The success of this consensus meeting shows the value of integrating results from surveillance, field experience and operational research for designing new health strategies.


Asunto(s)
Brotes de Enfermedades , Meningitis Meningocócica/epidemiología , África/epidemiología , Métodos Epidemiológicos , Humanos , Meningitis Meningocócica/prevención & control , Investigación Operativa , Guías de Práctica Clínica como Asunto , Factores de Riesgo
20.
J Infect Dis ; 182(4): 1169-76, 2000 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10979914

RESUMEN

Two hundred eighty-one sporadic Neisseria meningitidis serogroup B isolates, collected through active laboratory-based surveillance, were selected to be analyzed by PorA variable region (VR) typing to determine the prevalence of PorA types in the United States. A substantial number of distinct VR types were identified, 31 in VR1 and 41 in VR2. A total of 73 different PorA types were found, and 76. 7% of these types comprise nonprototype sequences in VR1, VR2, or both. The most prevalent PorA types were P1.7,16-20 (previously P1.7, 16i), P1.22,14, P1.22-1,14 (previously P1.22a,14), P1.7,16, P1.7-1,1 (previously P1.7d,1), P1.19,15, and P1.17,16-3 (previously P1.B,16d). No correlation was observed between the PorA types and geographic origin of the isolates. These data may aid in the design of an efficacious outer membrane protein-based vaccine by identifying the most appropriate PorA types for vaccine formulation. Studies are needed to fully evaluate the extent of cross-protection in humans among the variants and prototypes in each PorA VR family.


Asunto(s)
Variación Genética , Meningitis Meningocócica/microbiología , Neisseria meningitidis/clasificación , Porinas/genética , Centers for Disease Control and Prevention, U.S. , Humanos , Meningitis Meningocócica/epidemiología , Neisseria meningitidis/genética , Neisseria meningitidis/aislamiento & purificación , Vigilancia de la Población , Estados Unidos/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA